Showing results (1471-1480 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|November 1, 1993
VM-26 in gastric cancer. A Southwest Oncology Group studyJ L Berenberg, C Tangen, J S Macdonald, et al.
Investigational New Drugs|February 5, 2010
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell linesClaudio Celeghini, Rebecca Voltan, Erika Rimondi, et al.
Investigational New Drugs|December 10, 2009
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancerChul Kim, Jae-Lyun Lee, Min-Hee Ryu, et al.
Investigational New Drugs|December 10, 2009
ATP chemosensitivity testing of new antitumor duplex drugs linking 3`-C-ethynylycytidine (ECyd) and 2´-deoxy-5-fluorouridine (5-FdU) in comparison to standard cytostatica and combinations thereofSarah Schott, Markus Wallwiener, Beate Kootz, et al.
Investigational New Drugs|November 13, 2009
CYT997 causes apoptosis in human multiple myelomaKatherine Monaghan, Tiffany Khong, Gregg Smith, et al.
Investigational New Drugs|September 30, 2018
Clinical outcomes of patients with G1/G2 neuroendocrine tumors arising from foregut or hindgut treated with somatostatin analogs: a retrospective studyHanae Ida, Yoshitaka Honma, Hidekazu Hirano, et al.
Investigational New Drugs|October 14, 2018
Survival outcome and prognostic model of patients with colorectal cancer on phase 1 trialsAudrey E Kam, Gopichand Pendurti, Umang H Shah, et al.
Investigational New Drugs|October 17, 2018
Second-line chemotherapy in patients with advanced or recurrent biliary tract cancer: a single center, retrospective analysis of 294 casesNaminatsu Takahara, Yousuke Nakai, Hiroyuki Isayama, et al.
Investigational New Drugs|October 17, 2018
Prognostic factors in patients with metastatic or recurrent pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine: implication of inflammation-based scoresInhwan Hwang, Jihoon Kang, Hei Nga Natalie Ip, et al.
Investigational New Drugs|August 30, 2018
Hexane partition from Annona crassiflora Mart. promotes cytotoxity and apoptosis on human cervical cancer cell linesViviane A O Silva, Ana Laura V Alves, Marcela N Rosa, et al.
Pageof 372